Corning Incorporated (NYSE: GLW) today introduced the new Corning® Epic® BT System as it continues to drive the evolution of its Epic platform.
Corning’s benchtop label-free detection system features a compact design, a more affordable price point, simple data collection software, and whole microplate analysis using charge-coupled device (CCD) detection of wavelength shift. The new system improves assay capabilities and allows researchers, including academic laboratories, easy access to the Epic technology.
“The new Corning Epic BT is a compact, yet highly versatile, version of Corning’s Epic instrument, building upon its legacy of providing high-quality, label-free technology. It delivers all of the same information as the earlier version while also providing advanced features and functionality, including additional detection modality with valuable cellular information,” said Min Li, Ph.D., professor, Department of Neuroscience and director, Johns Hopkins Ion Channel Center, Johns Hopkins University School of Medicine. “We are excited to use this innovative system to develop ion channel assays.”
The Corning Epic BT System is the latest generation of Corning’s original Epic System, introduced in 2006 as the world’s first high-throughput, label-free screening system.
“Corning has a long history of innovation across a number of high-growth industries, including life sciences,” said Todd Upton, manager, Commercial Technology, Corning Life Sciences. “We understand that today’s researchers and laboratories are required to do more with less in shorter amounts of time while continuing to focus on quality. The Corning Epic BT utilizes best-in-class, label-free Epic technology and refined design principles to deliver an affordable, fast, and highly accurate solution.”
The New Corning Epic BT System features:
- No microplate movement; all wells are analyzed simultaneously
- Simple data collection software
- The ability to accept both Corning’s 96- and 384-well Epic microplate formats
- Enabling of both cell-based and biochemical assays
- Simplified detection; CCD instead of spectrometers
- Three-second whole microplate read time to better interpret fast biological events
- Compact and simplified instrument design
- Minimal moving parts, which helps reduce maintenance
- Smaller footprint; can be placed in any non-humidified laboratory incubator
- The ability to operate at 37 C inside an incubator
- Reduced cost for broader installation outside HTS core groups
With the introduction of Corning Epic BT, researchers now have a convenient and affordable option to access Corning’s high-quality, innovative, label-free Epic technology.
Corning Life Sciences continually brings new and innovative laboratory technologies to researchers worldwide. Corning helps customers succeed by providing innovative, high-quality products and services in the areas of polymer science, biochemistry and molecular biology, glass melting and forming, surface modification, and characterization science.
To learn more about Corning Epic BT or any Corning Life Sciences products, please contact a customer service representative at 1-800-492-1110, toll free in the United States; (+1) 1-978-442-2200 internationally; or visit www.corning.com/lifesciences .
Forward-Looking and Cautionary Statements
This press release contains “forward-looking statements” (within the meaning of the Private Securities Litigation Reform Act of 1995), which are based on current expectations and assumptions about Corning’s financial results and business operations, that involve substantial risks and uncertainties that could cause actual results to differ materially. These risks and uncertainties include: the effect of global political, economic and business conditions; conditions in the financial and credit markets; currency fluctuations; tax rates; product demand and industry capacity; competition; reliance on a concentrated customer base; manufacturing efficiencies; cost reductions; availability of critical components and materials; new product commercialization; pricing fluctuations and changes in the mix of sales between premium and non-premium products; new plant start-up or restructuring costs; possible disruption in commercial activities due to terrorist activity, armed conflict, political or financial instability, natural disasters, adverse weather conditions, or major health concerns; adequacy of insurance; equity company activities; acquisition and divestiture activities; the level of excess or obsolete inventory; the rate of technology change; the ability to enforce patents; product and components performance issues; retention of key personnel; stock price fluctuations; and adverse litigation or regulatory developments. These and other risk factors are detailed in Corning’s filings with the Securities and Exchange Commission. Forward-looking statements speak only as of the day that they are made, and Corning undertakes no obligation to update them in light of new information or future events.
About Corning Incorporated
Corning Incorporated ( www.corning.com ) is the world leader in specialty glass and ceramics. Drawing on more than 160 years of materials science and process engineering knowledge, Corning creates and makes keystone components that enable high-technology systems for consumer electronics, mobile emissions control, telecommunications and life sciences. Our products include glass substrates for LCD televisions, computer monitors and laptops; ceramic substrates and filters for mobile emission control systems; optical fiber, cable, hardware & equipment for telecommunications networks; optical biosensors for drug discovery; and other advanced optics and specialty glass solutions for a number of industries including semiconductor, aerospace, defense, astronomy, and metrology.